Home Casteddu.com FAQ My Amedeo About Flying Publisher   

The Medical Article of the Year 2008


  Dermatology

  Free Subscription


Articles published in Cancer Res

Retrieve available abstracts of 332 articles:
HTML format



Single Articles


    June 2008
  1. MONTAGUT C , Sharma SV, Shioda T, McDermott U, et al
    Elevated CRAF as a potential mechanism of acquired resistance to BRAF inhibition in melanoma.
    Cancer Res. 2008;68:4853-61.
    PubMed     Related articles    Abstract available


  2. WANG L , Damania B
    Kaposi's sarcoma-associated herpesvirus confers a survival advantage to endothelial cells.
    Cancer Res. 2008;68:4640-8.
    PubMed     Related articles    Abstract available


  3. CRUZ-MUNOZ W , Man S, Xu P, Kerbel RS, et al
    Development of a preclinical model of spontaneous human melanoma central nervous system metastasis.
    Cancer Res. 2008;68:4500-5.
    PubMed     Related articles    Abstract available


  4. MOLHOEK KR , Griesemann H, Shu J, Gershenwald JE, et al
    Human melanoma cytolysis by combined inhibition of mammalian target of rapamycin and vascular endothelial growth factor/vascular endothelial growth factor receptor-2.
    Cancer Res. 2008;68:4392-7.
    PubMed     Related articles    Abstract available


  5. LO RS , Witte ON
    Transforming growth factor-beta activation promotes genetic context-dependent invasion of immortalized melanocytes.
    Cancer Res. 2008;68:4248-57.
    PubMed     Related articles    Abstract available


    May 2008
  6. ZHENG D , Bode AM, Zhao Q, Cho YY, et al
    The cannabinoid receptors are required for ultraviolet-induced inflammation and skin cancer development.
    Cancer Res. 2008;68:3992-8.
    PubMed     Related articles    Abstract available


  7. CONNEROTTE T , Van Pel A, Godelaine D, Tartour E, et al
    Functions of Anti-MAGE T-Cells Induced in Melanoma Patients under Different Vaccination Modalities.
    Cancer Res. 2008;68:3931-3940.
    PubMed     Related articles    Abstract available


  8. YUSUF N , Nasti TH, Katiyar SK, Jacobs MK, et al
    Antagonistic Roles of CD4+ and CD8+ T-Cells in 7,12-Dimethylbenz(a)anthracene Cutaneous Carcinogenesis.
    Cancer Res. 2008;68:3924-30.
    PubMed     Related articles    Abstract available


  9. FANTIN VR , Loboda A, Paweletz CP, Hendrickson RC, et al
    Constitutive activation of signal transducers and activators of transcription predicts vorinostat resistance in cutaneous T-cell lymphoma.
    Cancer Res. 2008;68:3785-94.
    PubMed     Related articles    Abstract available


  10. AUGUSTINE CK , Yoshimoto Y, Gupta M, Zipfel PA, et al
    Targeting N-cadherin enhances antitumor activity of cytotoxic therapies in melanoma treatment.
    Cancer Res. 2008;68:3777-84.
    PubMed     Related articles    Abstract available


  11. MOORE T , Carbajal S, Beltran L, Perkins SN, et al
    Reduced susceptibility to two-stage skin carcinogenesis in mice with low circulating insulin-like growth factor I levels.
    Cancer Res. 2008;68:3680-8.
    PubMed     Related articles    Abstract available


  12. VAN KILSDONK JW , Wilting RH, Bergers M, van Muijen GN, et al
    Attenuation of Melanoma Invasion by a Secreted Variant of Activated Leukocyte Cell Adhesion Molecule.
    Cancer Res. 2008;68:3671-3679.
    PubMed     Related articles    Abstract available


  13. CHEUNG M , Sharma A, Madhunapantula SV, Robertson GP, et al
    Akt3 and mutant V600E B-Raf cooperate to promote early melanoma development.
    Cancer Res. 2008;68:3429-39.
    PubMed     Related articles    Abstract available


  14. MARSH D , Dickinson S, Neill GW, Marshall JF, et al
    alpha vbeta 6 Integrin promotes the invasion of morphoeic basal cell carcinoma through stromal modulation.
    Cancer Res. 2008;68:3295-303.
    PubMed     Related articles    Abstract available


  15. DYNEK JN , Chan SM, Liu J, Zha J, et al
    Microphthalmia-associated transcription factor is a critical transcriptional regulator of melanoma inhibitor of apoptosis in melanomas.
    Cancer Res. 2008;68:3124-32.
    PubMed     Related articles    Abstract available


  16. FARRUGIA DJ , Agarwal MK, Pankratz VS, Deffenbaugh AM, et al
    Functional assays for classification of BRCA2 variants of uncertain significance.
    Cancer Res. 2008;68:3523-31.
    PubMed     Related articles    Abstract available


  17. MACEDO LF , Sabnis GJ, Goloubeva OG, Brodie A, et al
    Combination of anastrozole with fulvestrant in the intratumoral aromatase xenograft model.
    Cancer Res. 2008;68:3516-22.
    PubMed     Related articles    Abstract available


  18. BARNETT DH , Sheng S, Charn TH, Waheed A, et al
    Estrogen receptor regulation of carbonic anhydrase XII through a distal enhancer in breast cancer.
    Cancer Res. 2008;68:3505-15.
    PubMed     Related articles    Abstract available


  19. BENDRIK C , Robertson J, Gauldie J, Dabrosin C, et al
    Gene transfer of matrix metalloproteinase-9 induces tumor regression of breast cancer in vivo.
    Cancer Res. 2008;68:3405-12.
    PubMed     Related articles    Abstract available


  20. MUELLER KL , Hunter LA, Ethier SP, Boerner JL, et al
    Met and c-Src cooperate to compensate for loss of epidermal growth factor receptor kinase activity in breast cancer cells.
    Cancer Res. 2008;68:3314-22.
    PubMed     Related articles    Abstract available


  21. YANG XH , Richardson AL, Torres-Arzayus MI, Zhou P, et al
    CD151 accelerates breast cancer by regulating alpha 6 integrin function, signaling, and molecular organization.
    Cancer Res. 2008;68:3204-13.
    PubMed     Related articles    Abstract available


  22. KAKLAMANI VG , Sadim M, Hsi A, Offit K, et al
    Variants of the adiponectin and adiponectin receptor 1 genes and breast cancer risk.
    Cancer Res. 2008;68:3178-84.
    PubMed     Related articles    Abstract available


  23. SMID M , Wang Y, Zhang Y, Sieuwerts AM, et al
    Subtypes of breast cancer show preferential site of relapse.
    Cancer Res. 2008;68:3108-14.
    PubMed     Related articles    Abstract available


    April 2008
  24. FELICETTI F , Errico MC, Bottero L, Segnalini P, et al
    The promyelocytic leukemia zinc finger-microRNA-221/-222 pathway controls melanoma progression through multiple oncogenic mechanisms.
    Cancer Res. 2008;68:2745-54.
    PubMed     Related articles    Abstract available


  25. CALDON CE , Swarbrick A, Lee CS, Sutherland RL, et al
    The helix-loop-helix protein Id1 requires cyclin D1 to promote the proliferation of mammary epithelial cell acini.
    Cancer Res. 2008;68:3026-36.
    PubMed     Related articles    Abstract available


  26. SHOR B , Zhang WG, Toral-Barza L, Lucas J, et al
    A new pharmacologic action of CCI-779 involves FKBP12-independent inhibition of mTOR kinase activity and profound repression of global protein synthesis.
    Cancer Res. 2008;68:2934-43.
    PubMed     Related articles    Abstract available


  27. AHMAD R , Raina D, Meyer C, Kufe D, et al
    Triterpenoid CDDO-methyl ester inhibits the Janus-activated kinase-1 (JAK1)-->signal transducer and activator of transcription-3 (STAT3) pathway by direct inhibition of JAK1 and STAT3.
    Cancer Res. 2008;68:2920-6.
    PubMed     Related articles    Abstract available


  28. SUN H , Berquin IM, Owens RT, O'Flaherty JT, et al
    Peroxisome proliferator-activated receptor gamma-mediated up-regulation of syndecan-1 by n-3 fatty acids promotes apoptosis of human breast cancer cells.
    Cancer Res. 2008;68:2912-9.
    PubMed     Related articles    Abstract available


  29. TRAN M , Rousselle P, Nokelainen P, Tallapragada S, et al
    Targeting a tumor-specific laminin domain critical for human carcinogenesis.
    Cancer Res. 2008;68:2885-94.
    PubMed     Related articles    Abstract available


  30. HAWSAWI NM , Ghebeh H, Hendrayani SF, Tulbah A, et al
    Breast carcinoma-associated fibroblasts and their counterparts display neoplastic-specific changes.
    Cancer Res. 2008;68:2717-25.
    PubMed     Related articles    Abstract available


  31. YAMADA N , Nishida Y, Tsutsumida H, Hamada T, et al
    MUC1 expression is regulated by DNA methylation and histone H3 lysine 9 modification in cancer cells.
    Cancer Res. 2008;68:2708-16.
    PubMed     Related articles    Abstract available


  32. VERMEER MH , van Doorn R, Dijkman R, Mao X, et al
    Novel and highly recurrent chromosomal alterations in Sezary syndrome.
    Cancer Res. 2008;68:2689-98.
    PubMed     Related articles    Abstract available


  33. SHAI A , Pitot HC, Lambert PF
    p53 Loss synergizes with estrogen and papillomaviral oncogenes to induce cervical and breast cancers.
    Cancer Res. 2008;68:2622-31.
    PubMed     Related articles    Abstract available


  34. CHAN SW , Lim CJ, Guo K, Ng CP, et al
    A role for TAZ in migration, invasion, and tumorigenesis of breast cancer cells.
    Cancer Res. 2008;68:2592-8.
    PubMed     Related articles    Abstract available


  35. LU YP , Lou YR, Peng QY, Xie JG, et al
    Effect of caffeine on the ATR/Chk1 pathway in the epidermis of UVB-irradiated mice.
    Cancer Res. 2008;68:2523-9.
    PubMed     Related articles    Abstract available


  36. ENGELMANN K , Shen H, Finn OJ
    MCF7 side population cells with characteristics of cancer stem/progenitor cells express the tumor antigen MUC1.
    Cancer Res. 2008;68:2419-26.
    PubMed     Related articles    Abstract available


  37. SOUNDARARAJAN S , Chen W, Spicer EK, Courtenay-Luck N, et al
    The nucleolin targeting aptamer AS1411 destabilizes Bcl-2 messenger RNA in human breast cancer cells.
    Cancer Res. 2008;68:2358-65.
    PubMed     Related articles    Abstract available


  38. WANG X , Masri S, Phung S, Chen S, et al
    The role of amphiregulin in exemestane-resistant breast cancer cells: evidence of an autocrine loop.
    Cancer Res. 2008;68:2259-65.
    PubMed     Related articles    Abstract available


  39. COLETTA RD , Christensen KL, Micalizzi DS, Jedlicka P, et al
    Six1 overexpression in mammary cells induces genomic instability and is sufficient for malignant transformation.
    Cancer Res. 2008;68:2204-13.
    PubMed     Related articles    Abstract available


  40. NAIK MU , Naik TU, Suckow AT, Duncan MK, et al
    Attenuation of junctional adhesion molecule-A is a contributing factor for breast cancer cell invasion.
    Cancer Res. 2008;68:2194-203.
    PubMed     Related articles    Abstract available


  41. SEIFEDDINE R , Dreiem A, Blanc E, Fulchignoni-Lataud MC, et al
    Hypoxia down-regulates CCAAT/enhancer binding protein-alpha expression in breast cancer cells.
    Cancer Res. 2008;68:2158-65.
    PubMed     Related articles    Abstract available


  42. ZHANG S , Phelan CM, Zhang P, Rousseau F, et al
    Frequency of the CHEK2 1100delC mutation among women with breast cancer: an international study.
    Cancer Res. 2008;68:2154-7.
    PubMed     Related articles    Abstract available


  43. DOURDIN N , Schade B, Lesurf R, Hallett M, et al
    Phosphatase and tensin homologue deleted on chromosome 10 deficiency accelerates tumor induction in a mouse model of ErbB-2 mammary tumorigenesis.
    Cancer Res. 2008;68:2122-31.
    PubMed     Related articles    Abstract available


  44. DAIRKEE SH , Seok J, Champion S, Sayeed A, et al
    Bisphenol A induces a profile of tumor aggressiveness in high-risk cells from breast cancer patients.
    Cancer Res. 2008;68:2076-80.
    PubMed     Related articles    Abstract available


    March 2008
  45. POS Z , Wiener Z, Pocza P, Racz M, et al
    Histamine suppresses fibulin-5 and insulin-like growth factor-II receptor expression in melanoma.
    Cancer Res. 2008;68:1997-2005.
    PubMed     Related articles    Abstract available


  46. SHIN YC , Joo CH, Gack MU, Lee HR, et al
    Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 3 stabilizes hypoxia-inducible factor-1 alpha to induce vascular endothelial growth factor expression.
    Cancer Res. 2008;68:1751-9.
    PubMed     Related articles    Abstract available


  47. ZHANG YX , Knyazev PG, Cheburkin YV, Sharma K, et al
    AXL is a potential target for therapeutic intervention in breast cancer progression.
    Cancer Res. 2008;68:1905-15.
    PubMed     Related articles    Abstract available


  48. YAMAGUCHI N , Oyama T, Ito E, Satoh H, et al
    NOTCH3 signaling pathway plays crucial roles in the proliferation of ErbB2-negative human breast cancer cells.
    Cancer Res. 2008;68:1881-8.
    PubMed     Related articles    Abstract available


  49. BIERIE B , Stover DG, Abel TW, Chytil A, et al
    Transforming growth factor-beta regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment.
    Cancer Res. 2008;68:1809-19.
    PubMed     Related articles    Abstract available


  50. CHENG AS , Culhane AC, Chan MW, Venkataramu CR, et al
    Epithelial progeny of estrogen-exposed breast progenitor cells display a cancer-like methylome.
    Cancer Res. 2008;68:1786-96.
    PubMed     Related articles    Abstract available


  51. DANES CG , Wyszomierski SL, Lu J, Neal CL, et al
    14-3-3 zeta down-regulates p53 in mammary epithelial cells and confers luminal filling.
    Cancer Res. 2008;68:1760-7.
    PubMed     Related articles    Abstract available


  52. SHEKHAR MP , Gerard B, Pauley RJ, Williams BO, et al
    Rad6B is a positive regulator of beta-catenin stabilization.
    Cancer Res. 2008;68:1741-50.
    PubMed     Related articles    Abstract available


  53. XIA W , Nagase S, Montia AG, Kalachikov SM, et al
    BAF180 is a critical regulator of p21 induction and a tumor suppressor mutated in breast cancer.
    Cancer Res. 2008;68:1667-74.
    PubMed     Related articles    Abstract available


  54. MCDONALD PC , Oloumi A, Mills J, Dobreva I, et al
    Rictor and integrin-linked kinase interact and regulate Akt phosphorylation and cancer cell survival.
    Cancer Res. 2008;68:1618-24.
    PubMed     Related articles    Abstract available


  55. BEMIS LT , Chen R, Amato CM, Classen EH, et al
    MicroRNA-137 targets microphthalmia-associated transcription factor in melanoma cell lines.
    Cancer Res. 2008;68:1362-8.
    PubMed     Related articles    Abstract available


  56. CHAKRABORTY AK , Liang K, DiGiovanna MP
    Co-targeting insulin-like growth factor I receptor and HER2: dramatic effects of HER2 inhibitors on nonoverexpressing breast cancer.
    Cancer Res. 2008;68:1538-45.
    PubMed     Related articles    Abstract available


  57. FUJII T , Kawahara A, Basaki Y, Hattori S, et al
    Expression of HER2 and estrogen receptor alpha depends upon nuclear localization of Y-box binding protein-1 in human breast cancers.
    Cancer Res. 2008;68:1504-12.
    PubMed     Related articles    Abstract available


  58. SHATTUCK DL , Miller JK, Carraway KL 3rd, Sweeney C, et al
    Met receptor contributes to trastuzumab resistance of Her2-overexpressing breast cancer cells.
    Cancer Res. 2008;68:1471-7.
    PubMed     Related articles    Abstract available


  59. LABELLE M , Schnittler HJ, Aust DE, Friedrich K, et al
    Vascular endothelial cadherin promotes breast cancer progression via transforming growth factor beta signaling.
    Cancer Res. 2008;68:1388-97.
    PubMed     Related articles    Abstract available


  60. RIZKI A , Weaver VM, Lee SY, Rozenberg GI, et al
    A human breast cell model of preinvasive to invasive transition.
    Cancer Res. 2008;68:1378-87.
    PubMed     Related articles    Abstract available


  61. PLOTNIKOV A , Li Y, Tran TH, Tang W, et al
    Oncogene-mediated inhibition of glycogen synthase kinase 3 beta impairs degradation of prolactin receptor.
    Cancer Res. 2008;68:1354-61.
    PubMed     Related articles    Abstract available


  62. MELIS JP , Wijnhoven SW, Beems RB, Roodbergen M, et al
    Mouse models for xeroderma pigmentosum group A and group C show divergent cancer phenotypes.
    Cancer Res. 2008;68:1347-53.
    PubMed     Related articles    Abstract available


  63. JIANG P , Enomoto A, Jijiwa M, Kato T, et al
    An actin-binding protein Girdin regulates the motility of breast cancer cells.
    Cancer Res. 2008;68:1310-8.
    PubMed     Related articles    Abstract available


  64. SCHMID T , Jansen AP, Baker AR, Hegamyer G, et al
    Translation inhibitor Pdcd4 is targeted for degradation during tumor promotion.
    Cancer Res. 2008;68:1254-60.
    PubMed     Related articles    Abstract available


    February 2008
  65. MARZEC M , Halasa K, Kasprzycka M, Wysocka M, et al
    Differential effects of interleukin-2 and interleukin-15 versus interleukin-21 on CD4+ cutaneous T-cell lymphoma cells.
    Cancer Res. 2008;68:1083-91.
    PubMed     Related articles    Abstract available


  66. GRAVES CW , Philips ST, Bradley SV, Oravecz-Wilson KI, et al
    Use of a cryptic splice site for the expression of huntingtin interacting protein 1 in select normal and neoplastic tissues.
    Cancer Res. 2008;68:1064-73.
    PubMed     Related articles    Abstract available


  67. FURUTA E , Pai SK, Zhan R, Bandyopadhyay S, et al
    Fatty acid synthase gene is up-regulated by hypoxia via activation of Akt and sterol regulatory element binding protein-1.
    Cancer Res. 2008;68:1003-11.
    PubMed     Related articles    Abstract available


  68. POTAPOVA A , Hoffman AM, Godwin AK, Al-Saleem T, et al
    Promoter hypermethylation of the PALB2 susceptibility gene in inherited and sporadic breast and ovarian cancer.
    Cancer Res. 2008;68:998-1002.
    PubMed     Related articles    Abstract available


  69. SARRIO D , Rodriguez-Pinilla SM, Hardisson D, Cano A, et al
    Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype.
    Cancer Res. 2008;68:989-97.
    PubMed     Related articles    Abstract available


  70. WANG X , Szabo C, Qian C, Amadio PG, et al
    Mutational analysis of thirty-two double-strand DNA break repair genes in breast and pancreatic cancers.
    Cancer Res. 2008;68:971-5.
    PubMed     Related articles    Abstract available


  71. CHEN LH , Jiang CC, Watts R, Thorne RF, et al
    Inhibition of endoplasmic reticulum stress-induced apoptosis of melanoma cells by the ARC protein.
    Cancer Res. 2008;68:834-42.
    PubMed     Related articles    Abstract available


  72. VALLACCHI V , Daniotti M, Ratti F, Di Stasi D, et al
    CCN3/nephroblastoma overexpressed matricellular protein regulates integrin expression, adhesion, and dissemination in melanoma.
    Cancer Res. 2008;68:715-23.
    PubMed     Related articles    Abstract available


  73. LIN WM , Baker AC, Beroukhim R, Winckler W, et al
    Modeling genomic diversity and tumor dependency in malignant melanoma.
    Cancer Res. 2008;68:664-73.
    PubMed     Related articles    Abstract available


  74. HOEK KS , Eichhoff OM, Schlegel NC, Dobbeling U, et al
    In vivo switching of human melanoma cells between proliferative and invasive states.
    Cancer Res. 2008;68:650-6.
    PubMed     Related articles    Abstract available


  75. LEE KW , Kang NJ, Heo YS, Rogozin EA, et al
    Raf and MEK protein kinases are direct molecular targets for the chemopreventive effect of quercetin, a major flavonol in red wine.
    Cancer Res. 2008;68:946-55.
    PubMed     Related articles    Abstract available


  76. TRIMBOLI AJ , Fukino K, de Bruin A, Wei G, et al
    Direct evidence for epithelial-mesenchymal transitions in breast cancer.
    Cancer Res. 2008;68:937-45.
    PubMed     Related articles    Abstract available


  77. SEGAL NH , Parsons DW, Peggs KS, Velculescu V, et al
    Epitope landscape in breast and colorectal cancer.
    Cancer Res. 2008;68:889-92.
    PubMed     Related articles    Abstract available


  78. ISHII Y , Waxman S, Germain D
    Tamoxifen stimulates the growth of cyclin D1-overexpressing breast cancer cells by promoting the activation of signal transducer and activator of transcription 3.
    Cancer Res. 2008;68:852-60.
    PubMed     Related articles    Abstract available


  79. MASSARWEH S , Osborne CK, Creighton CJ, Qin L, et al
    Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic function.
    Cancer Res. 2008;68:826-33.
    PubMed     Related articles    Abstract available


  80. YIN L , Castagnino P, Assoian RK
    ABCG2 expression and side population abundance regulated by a transforming growth factor beta-directed epithelial-mesenchymal transition.
    Cancer Res. 2008;68:800-7.
    PubMed     Related articles    Abstract available


  81. FINETTI P , Cervera N, Charafe-Jauffret E, Chabannon C, et al
    Sixteen-kinase gene expression identifies luminal breast cancers with poor prognosis.
    Cancer Res. 2008;68:767-76.
    PubMed     Related articles    Abstract available


  82. BREMM A , Walch A, Fuchs M, Mages J, et al
    Enhanced activation of epidermal growth factor receptor caused by tumor-derived E-cadherin mutations.
    Cancer Res. 2008;68:707-14.
    PubMed     Related articles    Abstract available


  83. YAROSH W , Barrientos T, Esmailpour T, Lin L, et al
    TBX3 is overexpressed in breast cancer and represses p14 ARF by interacting with histone deacetylases.
    Cancer Res. 2008;68:693-9.
    PubMed     Related articles    Abstract available


  84. MARTINEZ-CRUZ AB , Santos M, Lara MF, Segrelles C, et al
    Spontaneous squamous cell carcinoma induced by the somatic inactivation of retinoblastoma and Trp53 tumor suppressors.
    Cancer Res. 2008;68:683-92.
    PubMed     Related articles    Abstract available


  85. LEE JH , Horak CE, Khanna C, Meng Z, et al
    Alterations in Gemin5 expression contribute to alternative mRNA splicing patterns and tumor cell motility.
    Cancer Res. 2008;68:639-44.
    PubMed     Related articles    Abstract available


    January 2008
  86. YUSUF N , Nasti TH, Long JA, Naseemuddin M, et al
    Protective role of Toll-like receptor 4 during the initiation stage of cutaneous chemical carcinogenesis.
    Cancer Res. 2008;68:615-22.
    PubMed     Related articles    Abstract available


  87. MOSQUERA-MIGUEL A , Alvarez-Iglesias V, Carracedo A, Salas A, et al
    Is mitochondrial DNA variation associated with sporadic breast cancer risk?
    Cancer Res. 2008;68:623-5.
    PubMed     Related articles   


  88. SPADERNA S , Schmalhofer O, Wahlbuhl M, Dimmler A, et al
    The transcriptional repressor ZEB1 promotes metastasis and loss of cell polarity in cancer.
    Cancer Res. 2008;68:537-44.
    PubMed     Related articles    Abstract available


  89. ADLER AS , Littlepage LE, Lin M, Kawahara TL, et al
    CSN5 isopeptidase activity links COP9 signalosome activation to breast cancer progression.
    Cancer Res. 2008;68:506-15.
    PubMed     Related articles    Abstract available


  90. ZHAO X , Goswami M, Pokhriyal N, Ma H, et al
    Cyclooxygenase-2 expression during immortalization and breast cancer progression.
    Cancer Res. 2008;68:467-75.
    PubMed     Related articles    Abstract available


  91. WONG DJ , Nuyten DS, Regev A, Lin M, et al
    Revealing targeted therapy for human cancer by gene module maps.
    Cancer Res. 2008;68:369-78.
    PubMed     Related articles    Abstract available


  92. ADRIAENSSENS E , Vanhecke E, Saule P, Mougel A, et al
    Nerve growth factor is a potential therapeutic target in breast cancer.
    Cancer Res. 2008;68:346-51.
    PubMed     Related articles    Abstract available


  93. SARFARAZ S , Adhami VM, Syed DN, Afaq F, et al
    Cannabinoids for cancer treatment: progress and promise.
    Cancer Res. 2008;68:339-42.
    PubMed     Related articles    Abstract available


  94. SABATINO M , Zhao Y, Voiculescu S, Monaco A, et al
    Conservation of genetic alterations in recurrent melanoma supports the melanoma stem cell hypothesis.
    Cancer Res. 2008;68:122-31.
    PubMed     Related articles    Abstract available


  95. IKUTA S , Edamatsu H, Li M, Hu L, et al
    Crucial role of phospholipase C epsilon in skin inflammation induced by tumor-promoting phorbol ester.
    Cancer Res. 2008;68:64-72.
    PubMed     Related articles    Abstract available


  96. MADHUNAPANTULA SV , Robertson GP
    Is B-Raf a good therapeutic target for melanoma and other malignancies?
    Cancer Res. 2008;68:5-8.
    PubMed     Related articles    Abstract available


  97. FRIETZE S , Lupien M, Silver PA, Brown M, et al
    CARM1 regulates estrogen-stimulated breast cancer growth through up-regulation of E2F1.
    Cancer Res. 2008;68:301-6.
    PubMed     Related articles    Abstract available


  98. KONG X , Wang X, Xu W, Behera S, et al
    Natriuretic peptide receptor a as a novel anticancer target.
    Cancer Res. 2008;68:249-56.
    PubMed     Related articles    Abstract available


  99. CHAKRABORTY G , Jain S, Kundu GC
    Osteopontin promotes vascular endothelial growth factor-dependent breast tumor growth and angiogenesis via autocrine and paracrine mechanisms.
    Cancer Res. 2008;68:152-61.
    PubMed     Related articles    Abstract available


  100. AMANN M , Brischwein K, Lutterbuese P, Parr L, et al
    Therapeutic window of MuS110, a single-chain antibody construct bispecific for murine EpCAM and murine CD3.
    Cancer Res. 2008;68:143-51.
    PubMed     Related articles    Abstract available


  101. BRETSCHNEIDER N , Brand H, Miller N, Lowery AJ, et al
    Estrogen induces repression of the breast cancer and salivary gland expression gene in an estrogen receptor alpha-dependent manner.
    Cancer Res. 2008;68:106-14.
    PubMed     Related articles    Abstract available


  102. GURUMURTHY S , Hezel AF, Berger JH, Bosenberg MW, et al
    LKB1 deficiency sensitizes mice to carcinogen-induced tumorigenesis.
    Cancer Res. 2008;68:55-63.
    PubMed     Related articles    Abstract available


  103. GAO B , Xie XJ, Huang C, Shames DS, et al
    RASSF1A polymorphism A133S is associated with early onset breast cancer in BRCA1/2 mutation carriers.
    Cancer Res. 2008;68:22-5.
    PubMed     Related articles    Abstract available


  104. TAMIMI RM , Brugge JS, Freedman ML, Miron A, et al
    Circulating colony stimulating factor-1 and breast cancer risk.
    Cancer Res. 2008;68:18-21.
    PubMed     Related articles    Abstract available


    December 2007
  105. LIAO YH , Hsu SM, Huang PH
    ARMS depletion facilitates UV irradiation induced apoptotic cell death in melanoma.
    Cancer Res. 2007;67:11547-56.
    PubMed     Related articles    Abstract available


  106. VARCHETTA S , Gibelli N, Oliviero B, Nardini E, et al
    Elements related to heterogeneity of antibody-dependent cell cytotoxicity in patients under trastuzumab therapy for primary operable breast cancer overexpressing Her2.
    Cancer Res. 2007;67:11991-9.
    PubMed     Related articles    Abstract available


  107. LI L , Ryser S, Dizin E, Pils D, et al
    Oncogenic BARD1 isoforms expressed in gynecological cancers.
    Cancer Res. 2007;67:11876-85.
    PubMed     Related articles    Abstract available


  108. LEE HJ , Ji Y, Paul S, Maehr H, et al
    Activation of bone morphogenetic protein signaling by a Gemini vitamin D3 analogue is mediated by Ras/protein kinase C alpha.
    Cancer Res. 2007;67:11840-7.
    PubMed     Related articles    Abstract available


  109. WANG T , Zhao J, Ren JL, Zhang L, et al
    Recombinant immunoproapoptotic proteins with furin site can translocate and kill HER2-positive cancer cells.
    Cancer Res. 2007;67:11830-9.
    PubMed     Related articles    Abstract available


  110. GERMANIUK-KUROWSKA A , Nag A, Zhao X, Dimri M, et al
    Ada3 requirement for HAT recruitment to estrogen receptors and estrogen-dependent breast cancer cell proliferation.
    Cancer Res. 2007;67:11789-97.
    PubMed     Related articles    Abstract available


  111. O'CALLAGHAN-SUNOL C , Gabai VL, Sherman MY
    Hsp27 modulates p53 signaling and suppresses cellular senescence.
    Cancer Res. 2007;67:11779-88.
    PubMed     Related articles    Abstract available


  112. NANGIA-MAKKER P , Raz T, Tait L, Hogan V, et al
    Galectin-3 cleavage: a novel surrogate marker for matrix metalloproteinase activity in growing breast cancers.
    Cancer Res. 2007;67:11760-8.
    PubMed     Related articles    Abstract available


  113. HORAK CE , Mendoza A, Vega-Valle E, Albaugh M, et al
    Nm23-H1 suppresses metastasis by inhibiting expression of the lysophosphatidic acid receptor EDG2.
    Cancer Res. 2007;67:11751-9.
    PubMed     Related articles    Abstract available


  114. ESSEGHIR S , Todd SK, Hunt T, Poulsom R, et al
    A role for glial cell derived neurotrophic factor induced expression by inflammatory cytokines and RET/GFR alpha 1 receptor up-regulation in breast cancer.
    Cancer Res. 2007;67:11732-41.
    PubMed     Related articles    Abstract available


  115. OLMEDA D , Moreno-Bueno G, Flores JM, Fabra A, et al
    SNAI1 is required for tumor growth and lymph node metastasis of human breast carcinoma MDA-MB-231 cells.
    Cancer Res. 2007;67:11721-31.
    PubMed     Related articles    Abstract available


  116. SEMPERE LF , Christensen M, Silahtaroglu A, Bak M, et al
    Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer.
    Cancer Res. 2007;67:11612-20.
    PubMed     Related articles    Abstract available


  117. ADELAIDE J , Finetti P, Bekhouche I, Repellini L, et al
    Integrated profiling of basal and luminal breast cancers.
    Cancer Res. 2007;67:11565-75.
    PubMed     Related articles    Abstract available


  118. BRIDEAU G , Makinen MJ, Elamaa H, Tu H, et al
    Endostatin overexpression inhibits lymphangiogenesis and lymph node metastasis in mice.
    Cancer Res. 2007;67:11528-35.
    PubMed     Related articles    Abstract available


  119. HINSHELWOOD RA , Huschtscha LI, Melki J, Stirzaker C, et al
    Concordant epigenetic silencing of transforming growth factor-beta signaling pathway genes occurs early in breast carcinogenesis.
    Cancer Res. 2007;67:11517-27.
    PubMed     Related articles    Abstract available


  120. MILSTEIN M , Mooser CK, Hu H, Fejzo M, et al
    RIN1 is a breast tumor suppressor gene.
    Cancer Res. 2007;67:11510-6.
    PubMed     Related articles    Abstract available


  121. MOELLER M , Kershaw MH, Cameron R, Westwood JA, et al
    Sustained antigen-specific antitumor recall response mediated by gene-modified CD4+ T helper-1 and CD8+ T cells.
    Cancer Res. 2007;67:11428-37.
    PubMed     Related articles    Abstract available


  122. WESTBROOK L , Manuvakhova M, Kern FG, Estes NR 2nd, et al
    Cks1 regulates cdk1 expression: a novel role during mitotic entry in breast cancer cells.
    Cancer Res. 2007;67:11393-401.
    PubMed     Related articles    Abstract available


  123. NAIKI-ITO A , Asamoto M, Hokaiwado N, Takahashi S, et al
    Gpx2 is an overexpressed gene in rat breast cancers induced by three different chemical carcinogens.
    Cancer Res. 2007;67:11353-8.
    PubMed     Related articles    Abstract available


  124. MORI N , Glunde K, Takagi T, Raman V, et al
    Choline kinase down-regulation increases the effect of 5-fluorouracil in breast cancer cells.
    Cancer Res. 2007;67:11284-90.
    PubMed     Related articles    Abstract available


  125. YOKOTA T , Bui T, Liu Y, Yi M, et al
    Differential regulation of elafin in normal and tumor-derived mammary epithelial cells is mediated by CCAAT/enhancer binding protein beta.
    Cancer Res. 2007;67:11272-83.
    PubMed     Related articles    Abstract available


  126. KATOU F , Ohtani H, Watanabe Y, Nakayama T, et al
    Differing phenotypes between intraepithelial and stromal lymphocytes in early-stage tongue cancer.
    Cancer Res. 2007;67:11195-201.
    PubMed     Related articles    Abstract available


  127. LI N , Zheng Y, Chen W, Wang C, et al
    Adaptor protein LAPF recruits phosphorylated p53 to lysosomes and triggers lysosomal destabilization in apoptosis.
    Cancer Res. 2007;67:11176-85.
    PubMed     Related articles    Abstract available


  128. PALMER CP , Mahen R, Schnell E, Djamgoz MB, et al
    Sigma-1 receptors bind cholesterol and remodel lipid rafts in breast cancer cell lines.
    Cancer Res. 2007;67:11166-75.
    PubMed     Related articles    Abstract available


  129. EBI H , Matsuo K, Sugito N, Suzuki M, et al
    Novel NBS1 heterozygous germ line mutation causing MRE11-binding domain loss predisposes to common types of cancer.
    Cancer Res. 2007;67:11158-65.
    PubMed     Related articles    Abstract available


  130. HUANG Y , Fernandez SV, Goodwin S, Russo PA, et al
    Epithelial to mesenchymal transition in human breast epithelial cells transformed by 17beta-estradiol.
    Cancer Res. 2007;67:11147-57.
    PubMed     Related articles    Abstract available


  131. LIN J , Manson JE, Selhub J, Buring JE, et al
    Plasma cysteinylglycine levels and breast cancer risk in women.
    Cancer Res. 2007;67:11123-7.
    PubMed     Related articles    Abstract available


  132. RIZKI A , Mott JD, Bissell MJ
    Polo-like kinase 1 is involved in invasion through extracellular matrix.
    Cancer Res. 2007;67:11106-10.
    PubMed     Related articles    Abstract available


    November 2007
  133. SEGRELLES C , Lu J, Hammann B, Santos M, et al
    Deregulated Activity of Akt in Epithelial Basal Cells Induces Spontaneous Tumors and Heightened Sensitivity to Skin Carcinogenesis.
    Cancer Res. 2007;67:10879-10888.
    PubMed     Related articles    Abstract available


  134. BLACKBURN JS , Rhodes CH, Coon CI, Brinckerhoff CE, et al
    RNA Interference Inhibition of Matrix Metalloproteinase-1 Prevents Melanoma Metastasis by Reducing Tumor Collagenase Activity and Angiogenesis.
    Cancer Res. 2007;67:10849-10858.
    PubMed     Related articles    Abstract available


  135. MERTENS-TALCOTT SU , Chintharlapalli S, Li X, Safe S, et al
    The Oncogenic microRNA-27a Targets Genes That Regulate Specificity Protein Transcription Factors and the G2-M Checkpoint in MDA-MB-231 Breast Cancer Cells.
    Cancer Res. 2007;67:11001-11011.
    PubMed     Related articles    Abstract available


  136. MESLIN F , Hamai A, Gao P, Jalil A, et al
    Silencing of prion protein sensitizes breast adriamycin-resistant carcinoma cells to TRAIL-mediated cell death.
    Cancer Res. 2007;67:10910-9.
    PubMed     Related articles    Abstract available


  137. DOWLING RJ , Zakikhani M, Fantus IG, Pollak M, et al
    Metformin Inhibits Mammalian Target of Rapamycin Dependent Translation Initiation in Breast Cancer Cells.
    Cancer Res. 2007;67:10804-10812.
    PubMed     Related articles    Abstract available


  138. TRENT S , Yang C, Li C, Lynch M, et al
    Heat shock protein B8, a cyclin-dependent kinase-independent cyclin D1 target gene, contributes to its effects on radiation sensitivity.
    Cancer Res. 2007;67:10774-81.
    PubMed     Related articles    Abstract available


  139. SCHUNKE D , Span P, Ronneburg H, Dittmer A, et al
    Cyclooxygenase-2 Is a Target Gene of Rho GDP Dissociation Inhibitor {beta} in Breast Cancer Cells.
    Cancer Res. 2007;67:10694-10702.
    PubMed     Related articles    Abstract available


  140. ALEXE G , Dalgin GS, Scanfeld D, Tamayo P, et al
    High expression of lymphocyte-associated genes in node-negative HER2+ breast cancers correlates with lower recurrence rates.
    Cancer Res. 2007;67:10669-76.
    PubMed     Related articles    Abstract available


  141. PEREZ-GOMEZ E , Villa-Morales M, Santos J, Fernandez-Piqueras J, et al
    A Role for Endoglin as a Suppressor of Malignancy during Mouse Skin Carcinogenesis.
    Cancer Res. 2007;67:10268-10277.
    PubMed     Related articles    Abstract available


  142. LUKE CT , Oki-Idouchi CE, Cline JM, Lorenzo PS, et al
    RasGRP1 Overexpression in the Epidermis of Transgenic Mice Contributes to Tumor Progression during Multistage Skin Carcinogenesis.
    Cancer Res. 2007;67:10190-10197.
    PubMed     Related articles    Abstract available


  143. CURTIS CD , Likhite VS, McLeod IX, Yates JR, et al
    Interaction of the tumor metastasis suppressor nonmetastatic protein 23 homologue H1 and estrogen receptor alpha alters estrogen-responsive gene expression.
    Cancer Res. 2007;67:10600-7.
    PubMed     Related articles    Abstract available


  144. HARRELL JC , Dye WW, Harvell DM, Pinto M, et al
    Estrogen Insensitivity in a Model of Estrogen Receptor Positive Breast Cancer Lymph Node Metastasis.
    Cancer Res. 2007;67:10582-10591.
    PubMed     Related articles    Abstract available


  145. DOMCHEK SM , Recio A, Mick R, Clark CE, et al
    Telomerase-Specific T-Cell Immunity in Breast Cancer: Effect of Vaccination on Tumor Immunosurveillance.
    Cancer Res. 2007;67:10546-10555.
    PubMed     Related articles    Abstract available


  146. SANKALA HM , Hait NC, Paugh SW, Shida D, et al
    Involvement of sphingosine kinase 2 in p53-independent induction of p21 by the chemotherapeutic drug doxorubicin.
    Cancer Res. 2007;67:10466-74.
    PubMed     Related articles    Abstract available


  147. SCUTO A , Zhang H, Zhao H, Rivera M, et al
    RbAp48 regulates cytoskeletal organization and morphology by increasing K-Ras activity and signaling through mitogen-activated protein kinase.
    Cancer Res. 2007;67:10317-24.
    PubMed     Related articles    Abstract available


  148. MOREAU JE , Anderson K, Mauney JR, Nguyen T, et al
    Tissue-Engineered Bone Serves as a Target for Metastasis of Human Breast Cancer in a Mouse Model.
    Cancer Res. 2007;67:10304-10308.
    PubMed     Related articles    Abstract available


  149. DATTA S , Hoenerhoff MJ, Bommi P, Sainger R, et al
    Bmi-1 cooperates with H-Ras to transform human mammary epithelial cells via dysregulation of multiple growth-regulatory pathways.
    Cancer Res. 2007;67:10286-95.
    PubMed     Related articles    Abstract available


  150. WIENKE D , Davies GC, Johnson DA, Sturge J, et al
    The collagen receptor Endo180 (CD280) Is expressed on basal-like breast tumor cells and promotes tumor growth in vivo.
    Cancer Res. 2007;67:10230-40.
    PubMed     Related articles    Abstract available


  151. DECOCK J , Long JR, Laxton RC, Shu XO, et al
    Association of Matrix Metalloproteinase-8 Gene Variation with Breast Cancer Prognosis.
    Cancer Res. 2007;67:10214-10221.
    PubMed     Related articles    Abstract available


  152. ZHANG L , Wali A, Ramana CV, Rishi AK, et al
    Cell growth inhibition by okadaic acid involves gut-enriched Kruppel-like factor mediated enhanced expression of c-Myc.
    Cancer Res. 2007;67:10198-206.
    PubMed     Related articles    Abstract available


  153. YANG XR , Pfeiffer RM, Garcia-Closas M, Rimm DL, et al
    Hormonal Markers in Breast Cancer: Coexpression, Relationship with Pathologic Characteristics, and Risk Factor Associations in a Population-Based Study.
    Cancer Res. 2007;67:10608-10617.
    PubMed     Related articles    Abstract available   Free Full Text


    October 2007
  154. HUANG X , Yamada Y, Kidoya H, Naito H, et al
    EphB4 Overexpression in B16 Melanoma Cells Affects Arterial-Venous Patterning in Tumor Angiogenesis.
    Cancer Res. 2007;67:9800-8.
    PubMed     Related articles    Abstract available


  155. HORTON LW , Yu Y, Zaja-Milatovic S, Strieter RM, et al
    Opposing roles of murine duffy antigen receptor for chemokine and murine CXC chemokine receptor-2 receptors in murine melanoma tumor growth.
    Cancer Res. 2007;67:9791-9.
    PubMed     Related articles    Abstract available


  156. JIANG CC , Chen LH, Gillespie S, Wang YF, et al
    Inhibition of MEK Sensitizes Human Melanoma Cells to Endoplasmic Reticulum Stress-Induced Apoptosis.
    Cancer Res. 2007;67:9750-61.
    PubMed     Related articles    Abstract available


  157. ZHANG Q , Yu YA, Wang E, Chen N, et al
    Eradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virus.
    Cancer Res. 2007;67:10038-46.
    PubMed     Related articles    Abstract available


  158. AHN KS , Gong X, Sethi G, Chaturvedi MM, et al
    Deficiency of NRH:quinone oxidoreductase 2 differentially regulates TNF signaling in keratinocytes: up-regulation of apoptosis correlates with down-regulation of cell survival kinases.
    Cancer Res. 2007;67:10004-11.
    PubMed     Related articles    Abstract available


  159. RIDER DA , Havenith CE, de Ridder R, Schuurman J, et al
    A human CD4 monoclonal antibody for the treatment of T-cell lymphoma combines inhibition of T-cell signaling by a dual mechanism with potent fc-dependent effector activity.
    Cancer Res. 2007;67:9945-53.
    PubMed     Related articles    Abstract available


  160. LIANG Y , Besch-Williford C, Brekken RA, Hyder SM, et al
    Progestin-dependent progression of human breast tumor xenografts: a novel model for evaluating antitumor therapeutics.
    Cancer Res. 2007;67:9929-36.
    PubMed     Related articles    Abstract available


  161. LE GALL C , Bellahcene A, Bonnelye E, Gasser JA, et al
    A cathepsin k inhibitor reduces breast cancer induced osteolysis and skeletal tumor burden.
    Cancer Res. 2007;67:9894-902.
    PubMed     Related articles    Abstract available


  162. JANI JP , Finn RS, Campbell M, Coleman KG, et al
    Discovery and pharmacologic characterization of CP-724,714, a selective ErbB2 tyrosine kinase inhibitor.
    Cancer Res. 2007;67:9887-93.
    PubMed     Related articles    Abstract available


  163. MONTEL V , Gaultier A, Lester RD, Campana WM, et al
    The low-density lipoprotein receptor-related protein regulates cancer cell survival and metastasis development.
    Cancer Res. 2007;67:9817-24.
    PubMed     Related articles    Abstract available


  164. ANDRES-PONS A , Rodriguez-Escudero I, Gil A, Blanco A, et al
    In vivo functional analysis of the counterbalance of hyperactive phosphatidylinositol 3-kinase p110 catalytic oncoproteins by the tumor suppressor PTEN.
    Cancer Res. 2007;67:9731-9.
    PubMed     Related articles    Abstract available


  165. MACIAS E , Kim Y, Miliani de Marval PL, Klein-Szanto A, et al
    Cdk2 deficiency decreases ras/CDK4-dependent malignant progression, but not myc-induced tumorigenesis.
    Cancer Res. 2007;67:9713-20.
    PubMed     Related articles    Abstract available


  166. MARTIN RW , Orelli BJ, Yamazoe M, Minn AJ, et al
    RAD51 up-regulation bypasses BRCA1 function and is a common feature of BRCA1-deficient breast tumors.
    Cancer Res. 2007;67:9658-65.
    PubMed     Related articles    Abstract available


  167. NISHIKAWA N , Toyota M, Suzuki H, Honma T, et al
    Gene amplification and overexpression of PRDM14 in breast cancers.
    Cancer Res. 2007;67:9649-57.
    PubMed     Related articles    Abstract available


  168. SEYNHAEVE AL , Hoving S, Schipper D, Vermeulen CE, et al
    Tumor Necrosis Factor {alpha} Mediates Homogeneous Distribution of Liposomes in Murine Melanoma that Contributes to a Better Tumor Response.
    Cancer Res. 2007;67:9455-62.
    PubMed     Related articles    Abstract available


  169. DENICOURT C , Saenz CC, Datnow B, Cui XS, et al
    Relocalized p27Kip1 Tumor Suppressor Functions as a Cytoplasmic Metastatic Oncogene in Melanoma.
    Cancer Res. 2007;67:9238-43.
    PubMed     Related articles    Abstract available


  170. PARK E , Zhu F, Liu B, Xia X, et al
    Reduction in I{kappa}B Kinase {alpha} Expression Promotes the Development of Skin Papillomas and Carcinomas.
    Cancer Res. 2007;67:9158-68.
    PubMed     Related articles    Abstract available


  171. JONES R , Ruas M, Gregory F, Moulin S, et al
    A CDKN2A Mutation in Familial Melanoma that Abrogates Binding of p16INK4a to CDK4 but not CDK6.
    Cancer Res. 2007;67:9134-41.
    PubMed     Related articles    Abstract available


  172. LAUBER SN , Gooderham NJ
    The Cooked Meat Derived Genotoxic Carcinogen 2-Amino-3-Methylimidazo[4,5-b]Pyridine Has Potent Hormone-Like Activity: Mechanistic Support for a Role in Breast Cancer.
    Cancer Res. 2007;67:9597-602.
    PubMed     Related articles    Abstract available


  173. BERWICK M , Satagopan JM, Ben-Porat L, Carlson A, et al
    Genetic heterogeneity among Fanconi anemia heterozygotes and risk of cancer.
    Cancer Res. 2007;67:9591-6.
    PubMed     Related articles    Abstract available


  174. SCHMIDT MK , Reincke S, Broeks A, Braaf LM, et al
    Do MDM2 SNP309 and TP53 R72P Interact in Breast Cancer Susceptibility? A Large Pooled Series from the Breast Cancer Association Consortium.
    Cancer Res. 2007;67:9584-90.
    PubMed     Related articles    Abstract available


  175. HONG S , Lee C, Kim SJ
    Smad7 sensitizes tumor necrosis factor induced apoptosis through the inhibition of antiapoptotic gene expression by suppressing activation of the nuclear factor-kappaB pathway.
    Cancer Res. 2007;67:9577-83.
    PubMed     Related articles    Abstract available


  176. WITTMANN BM , Sherk A, McDonnell DP
    Definition of functionally important mechanistic differences among selective estrogen receptor down-regulators.
    Cancer Res. 2007;67:9549-60.
    PubMed     Related articles    Abstract available


  177. ZHENG Y , Zhou H, Modzelewski JR, Kalak R, et al
    Accelerated bone resorption, due to dietary calcium deficiency, promotes breast cancer tumor growth in bone.
    Cancer Res. 2007;67:9542-8.
    PubMed     Related articles    Abstract available


  178. KOSLOWSKI M , Sahin U, Mitnacht-Kraus R, Seitz G, et al
    A placenta-specific gene ectopically activated in many human cancers is essentially involved in malignant cell processes.
    Cancer Res. 2007;67:9528-34.
    PubMed     Related articles    Abstract available


  179. JAKOBSEN CG , Rasmussen N, Laenkholm AV, Ditzel HJ, et al
    Phage Display Derived Human Monoclonal Antibodies Isolated by Binding to the Surface of Live Primary Breast Cancer Cells Recognize GRP78.
    Cancer Res. 2007;67:9507-17.
    PubMed     Related articles    Abstract available


  180. AQEILAN RI , Donati V, Gaudio E, Nicoloso MS, et al
    Association of Wwox with ErbB4 in Breast Cancer.
    Cancer Res. 2007;67:9330-6.
    PubMed     Related articles    Abstract available


  181. DEGEN M , Brellier F, Kain R, Ruiz C, et al
    Tenascin-W Is a Novel Marker for Activated Tumor Stroma in Low-grade Human Breast Cancer and Influences Cell Behavior.
    Cancer Res. 2007;67:9169-79.
    PubMed     Related articles    Abstract available


  182. YAN W , Chen X
    Targeted Repression of Bone Morphogenetic Protein 7, a Novel Target of the p53 Family, Triggers Proliferative Defect in p53-Deficient Breast Cancer Cells.
    Cancer Res. 2007;67:9117-24.
    PubMed     Related articles    Abstract available


  183. LO HW , Hsu SC, Xia W, Cao X, et al
    Epidermal growth factor receptor cooperates with signal transducer and activator of transcription 3 to induce epithelial-mesenchymal transition in cancer cells via up-regulation of TWIST gene expression.
    Cancer Res. 2007;67:9066-76.
    PubMed     Related articles    Abstract available


  184. GADI VK , Nelson JL
    Fetal microchimerism in women with breast cancer.
    Cancer Res. 2007;67:9035-8.
    PubMed     Related articles    Abstract available


  185. LAPIERRE M , Siegfried G, Scamuffa N, Bontemps Y, et al
    Opposing Function of the Proprotein Convertases Furin and PACE4 on Breast Cancer Cells' Malignant Phenotypes: Role of Tissue Inhibitors of Metalloproteinase-1.
    Cancer Res. 2007;67:9030-4.
    PubMed     Related articles    Abstract available


  186. EDDY SF , Kane SE, Sonenshein GE
    Trastuzumab-Resistant HER2-Driven Breast Cancer Cells Are Sensitive to Epigallocatechin-3 Gallate.
    Cancer Res. 2007;67:9018-23.
    PubMed     Related articles    Abstract available


    September 2007
  187. MELANA SM , Nepomnaschy I, Sakalian M, Abbott A, et al
    Characterization of viral particles isolated from primary cultures of human breast cancer cells.
    Cancer Res. 2007;67:8960-5.
    PubMed     Related articles    Abstract available


  188. MCGOWAN EM , Russell AJ, Boonyaratanakornkit V, Saunders DN, et al
    Progestins Reinitiate Cell Cycle Progression in Antiestrogen-Arrested Breast Cancer Cells through the B-Isoform of Progesterone Receptor.
    Cancer Res. 2007;67:8942-51.
    PubMed     Related articles    Abstract available


  189. CHEN D , Reierstad S, Lin Z, Lu M, et al
    Prostaglandin E2 Induces Breast Cancer Related Aromatase Promoters via Activation of p38 and c-Jun NH2-Terminal Kinase in Adipose Fibroblasts.
    Cancer Res. 2007;67:8914-22.
    PubMed     Related articles    Abstract available


  190. MIAO ZH , Player A, Shankavaram U, Wang YH, et al
    Nonclassic functions of human topoisomerase I: genome-wide and pharmacologic analyses.
    Cancer Res. 2007;67:8752-61.
    PubMed     Related articles    Abstract available


  191. BUIJS JT , Henriquez NV, van Overveld PG, van der Horst G, et al
    Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.
    Cancer Res. 2007;67:8742-51.
    PubMed     Related articles    Abstract available


  192. HARPER J , Yan L, Loureiro RM, Wu I, et al
    Repression of vascular endothelial growth factor expression by the zinc finger transcription factor ZNF24.
    Cancer Res. 2007;67:8736-41.
    PubMed     Related articles    Abstract available


  193. LI X , Shen L, Zhang J, Su J, et al
    Degradation of HER2 by Cbl-based chimeric ubiquitin ligases.
    Cancer Res. 2007;67:8716-24.
    PubMed     Related articles    Abstract available


  194. TANG B , Yoo N, Vu M, Mamura M, et al
    Transforming Growth Factor-{beta} Can Suppress Tumorigenesis through Effects on the Putative Cancer Stem or Early Progenitor Cell and Committed Progeny in a Breast Cancer Xenograft Model.
    Cancer Res. 2007;67:8643-52.
    PubMed     Related articles    Abstract available


  195. SENG S , Avraham HK, Jiang S, Yang S, et al
    The Nuclear Matrix Protein, NRP/B, Enhances Nrf2-Mediated Oxidative Stress Responses in Breast Cancer Cells.
    Cancer Res. 2007;67:8596-604.
    PubMed     Related articles    Abstract available


  196. GONZALEZ ME , Peterson EA, Privette LM, Loffreda-Wren JL, et al
    High SEPT9_v1 Expression in Human Breast Cancer Cells Is Associated with Oncogenic Phenotypes.
    Cancer Res. 2007;67:8554-64.
    PubMed     Related articles    Abstract available


  197. KONISHI H , Karakas B, Abukhdeir AM, Lauring J, et al
    Knock-in of mutant K-ras in nontumorigenic human epithelial cells as a new model for studying K-ras mediated transformation.
    Cancer Res. 2007;67:8460-7.
    PubMed     Related articles    Abstract available


  198. WOODFIELD GW , Horan AD, Chen Y, Weigel RJ, et al
    TFAP2C Controls Hormone Response in Breast Cancer Cells through Multiple Pathways of Estrogen Signaling.
    Cancer Res. 2007;67:8439-43.
    PubMed     Related articles    Abstract available


  199. HUDSON TS , Hartle DK, Hursting SD, Nunez NP, et al
    Inhibition of Prostate Cancer Growth by Muscadine Grape Skin Extract and Resveratrol through Distinct Mechanisms.
    Cancer Res. 2007;67:8396-405.
    PubMed     Related articles    Abstract available


  200. O'SHAUGHNESSY RF , Akgul B, Storey A, Pfister H, et al
    Cutaneous Human Papillomaviruses Down-regulate AKT1, whereas AKT2 Up-regulation and Activation Associates with Tumors.
    Cancer Res. 2007;67:8207-8215.
    PubMed     Related articles    Abstract available


  201. VACHON CM , Sellers TA, Carlson EE, Cunningham JM, et al
    Strong evidence of a genetic determinant for mammographic density, a major risk factor for breast cancer.
    Cancer Res. 2007;67:8412-8.
    PubMed     Related articles    Abstract available


  202. KLUCKY B , Mueller R, Vogt I, Teurich S, et al
    Kallikrein 6 induces E-cadherin shedding and promotes cell proliferation, migration, and invasion.
    Cancer Res. 2007;67:8198-206.
    PubMed     Related articles    Abstract available


  203. BROMBERG KD , Kluger HM, Delaunay A, Abbas S, et al
    Increased Expression of the E3 Ubiquitin Ligase RNF5 Is Associated with Decreased Survival in Breast Cancer.
    Cancer Res. 2007;67:8172-9.
    PubMed     Related articles    Abstract available


  204. HITOSUGI T , Sato M, Sasaki K, Umezawa Y, et al
    Lipid raft specific knockdown of SRC family kinase activity inhibits cell adhesion and cell cycle progression of breast cancer cells.
    Cancer Res. 2007;67:8139-48.
    PubMed     Related articles    Abstract available


  205. DEEB KK , Michalowska AM, Yoon CY, Krummey SM, et al
    Identification of an integrated SV40 T/t-antigen cancer signature in aggressive human breast, prostate, and lung carcinomas with poor prognosis.
    Cancer Res. 2007;67:8065-80.
    PubMed     Related articles    Abstract available


  206. YUAN Y , Qin L, Liu D, Wu RC, et al
    Genetic Screening Reveals an Essential Role of p27kip1 in Restriction of Breast Cancer Progression.
    Cancer Res. 2007;67:8032-42.
    PubMed     Related articles    Abstract available


  207. CHEN H , Zhang H, Lee J, Liang X, et al
    HOXA5 acts directly downstream of retinoic acid receptor beta and contributes to retinoic acid-induced apoptosis and growth inhibition.
    Cancer Res. 2007;67:8007-13.
    PubMed     Related articles    Abstract available


  208. KOMINSKY SL , Tyler B, Sosnowski J, Brady K, et al
    Clostridium perfringens Enterotoxin as a Novel-Targeted Therapeutic for Brain Metastasis.
    Cancer Res. 2007;67:7977-82.
    PubMed     Related articles    Abstract available


  209. CELIS E
    Toll-like receptor ligands energize peptide vaccines through multiple paths.
    Cancer Res. 2007;67:7945-7.
    PubMed     Related articles    Abstract available


    August 2007
  210. PERROTTA C , Bizzozero L, Falcone S, Rovere-Querini P, et al
    Nitric Oxide Boosts Chemoimmunotherapy via Inhibition of Acid Sphingomyelinase in a Mouse Model of Melanoma.
    Cancer Res. 2007;67:7559-64.
    PubMed     Related articles    Abstract available


  211. MA C , Wang J, Gao Y, Gao TW, et al
    The role of glycogen synthase kinase 3beta in the transformation of epidermal cells.
    Cancer Res. 2007;67:7756-64.
    PubMed     Related articles  &